Shepherd Center and Hocoma to Showcase Robotic Rehabilitation Technology at Neurorehabilitation Symposium in August
Shepherd Center will co-host and serve as the conference site for the 2010 North American Neurorehabilitation Symposium organized with Hocoma, the medical technology company based in Switzerland that specializes in robotic rehabilitation therapy for neurological movement disorders, including Lokomat®, Armeo® and Erigo®.
The event will be held at Shepherd Center on Aug. 27-28, 2010. Topics include new information in neurorehabilitation, motor learning and motor control, robotic technology in rehabilitation, and motivating patients with virtual environments, as well as research in spinal cord injury, stroke, traumatic brain injury, cerebral palsy and other pathologies.
The conference is expected to bring together scientists and engineers from highly-recognized institutions worldwide and clinical users of innovative therapeutic methods and technologies.
Applications for continued education credit have been applied for through the Georgia Association of Occupational Therapists and the Physical Therapy Association of Georgia for 8.0 contact hours (0.80 CEUs).
The event is intended to offer clinicians and scientists a valuable platform to discuss trends, to share expertise, to exchange ideas and to gain knowledge to assess and use new technologies and therapy concepts in their daily practice.
For more information, visit the North American Neurorehabilitation Symposium Web site.
Shepherd Center, located in Atlanta, Georgia, is a private, not-for-profit hospital specializing in medical treatment, research and rehabilitation for people with spinal cord injury, brain injury, multiple sclerosis, spine and chronic pain, and other neuromuscular conditions. Founded in 1975, Shepherd Center is ranked by U.S. News & World Report among the top 10 rehabilitation hospitals in the nation. In its more than four decades, Shepherd Center has grown from a six-bed rehabilitation unit to a world-renowned, 152-bed hospital that treats more than 935 inpatients, 541 day program patients and more than 7,300 outpatients each year.